Examkin

Question

Difficulty: HardHematology and Oncology

A 68-year-old man is evaluated in the surgical intensive care unit on postoperative day 7 following a coronary artery bypass graft. He has been receiving prophylactic subcutaneous unfractionated heparin since surgery. His temperature is 37.1∘C37.1^\circ C (98.8∘F98.8^\circ F), blood pressure is 135/85135/85 mmHg, pulse is 9292/min, and respiratory rate is 1616/min. His preoperative platelet count was 260,000/mm3260,000/mm^3. Today, his routine complete blood count reveals a platelet count of 85,000/mm385,000/mm^3. Physical examination is notable for new right calf swelling and a necrotic skin lesion at a recent heparin injection site on his abdomen. A lower extremity venous duplex ultrasound is performed, which reveals a noncompressible right popliteal vein consistent with a deep vein thrombosis. The patient's 4T score is calculated as 7, indicating a high clinical probability for heparin-induced thrombocytopenia (HIT).

Arrange the following diagnostic and therapeutic steps in the most appropriate chronological sequence for this patient's management.

  1. 1Discontinue all heparin-containing medications, including prophylactic subcutaneous doses and catheter flushes.
  2. 2Initiate therapeutic anticoagulation with a non-heparin parenteral agent (e.g., argatroban or bivalirudin).
  3. 3Confirm the diagnosis of heparin-induced thrombocytopenia using a specific functional laboratory test.
  4. 4Transition to oral warfarin therapy only after the patient's platelet count has recovered to ≥150,000/mm3\geq 150,000/mm^3.

Answer

The correct sequence is to first discontinue all heparin products, then initiate a non-heparin anticoagulant, followed by definitive laboratory confirmation of HIT, and finally transition to warfarin only after platelet recovery.
The correct sequence for managing highly suspected Heparin-Induced Thrombocytopenia (HIT) emphasizes immediate clinical intervention over delayed diagnostic certainty. The first step is the absolute cessation of all heparin products to eliminate the immunogenic trigger. Second, because HIT is an intensely prothrombotic state (evidenced here by a new DVT despite thrombocytopenia), empiric therapeutic anticoagulation with a non-heparin agent (like argatroban or bivalirudin) must be initiated immediately. Third, laboratory confirmation using screening and highly specific functional tests (such as the Serotonin Release Assay) is pursued while the patient is safely anticoagulated. Finally, bridging to oral warfarin is delayed until the acute phase resolves (platelet count ≥150,000/mm3\geq 150,000/mm^3) to avoid the dreaded complication of warfarin-induced venous limb gangrene.

Step-by-Step Solution

1
Recognize high-probability Heparin-Induced Thrombocytopenia (HIT).
Identify the need for immediate intervention without waiting for laboratory confirmation.
A 4T score of 7 indicates a high clinical probability of HIT, necessitating emergency management to prevent catastrophic thrombosis.
2
Place 'Discontinue all heparin-containing medications...' as the first step.
Removal of the immunogenic trigger.
Halting the exposure to heparin is the primary requirement to stop the formation of PF4-heparin antibody complexes.
3
Place 'Initiate therapeutic anticoagulation with a non-heparin parenteral agent...' as the second step.
Immediate empiric treatment of the prothrombotic state.
Patients with HIT have a 50% risk of developing a new thrombosis if untreated; non-heparin anticoagulation must be started empirically before diagnostic assays result.
4
Place 'Confirm the diagnosis...' as the third step, and 'Transition to oral warfarin...' as the final step.
Appropriate diagnostic follow-up and safe long-term management.
Diagnostic confirmation occurs concurrently with treatment, and warfarin cannot be started until platelets recover to ≥150,000/mm3\geq 150,000/mm^3 due to the risk of venous limb gangrene.

Key Concept

In highly suspected Heparin-Induced Thrombocytopenia (HIT), all heparin must be stopped immediately and a non-heparin anticoagulant started empirically; warfarin is contraindicated until the platelet count has fully recovered.
Estimated Time:1m 30s
Rate this question

Topics

Hematology and Oncology

More questions from this topic